{"nct_id": "NCT05778708", "age": "Adults", "cancer_center_accrual_goal_upper": 0, "data_table4": "Interventional", "drug_list": {"drug": [{"drug_name": "Behavioral: Tai-Chi intervention"}, {"drug_name": "Behavioral: Aerobic exercise intervention"}]}, "long_title": "Tai-Chi and Aerobic Exercise to Improve Emotional Symptom Cluster in Late-stage Lung Cancer Patients", "management_group_list": {"management_group": [{"is_primary": "Y", "management_group_name": "Group1"}]}, "oncology_group_list": {"oncology_group": [{"group_name": "Group1", "is_primary": "N"}]}, "phase": "NA", "principal_investigator": "", "principal_investigator_institution": "The University of Hong Kong", "program_area_list": {"program_area": [{"is_primary": "Y", "program_area_name": "Program1"}]}, "protocol_id": 0, "protocol_no": "", "protocol_target_accrual": 318, "protocol_type": "INTERVENTIONAL", "prior_treatment_requirements": ["Inclusion Criteria:", "* diagnosed with stage IIIB or IV non-small cell lung cancer confirmed by pathology, with no other cancer diagnosis within the previous year;", "* a current Eastern Cooperative Oncology Group Performance Status of 0-2;", "* experience of sleep disturbance, anxiety, depression, and fatigue in the past week (rating of 1 or more on a 0-10 numeric rating scale \\[NRS\\] for each symptom);", "* able to communicate in Cantonese, Mandarin, or English;", "* conscious and alert", "Exclude - Exclusion Criteria:", "Exclude - * suffering from a condition that hinders exercise performance (e.g., active neurological disorder, recent heart attack);", "Exclude - * currently participating in any other exercise or mind-body classes; or 3) performing regular exercises, defined as at least 150 minutes of moderate-intensity exercise weekly"], "short_title": "Tai-Chi and Aerobic Exercise to Improve Emotional Symptom Cluster in Late-stage Lung Cancer Patients", "site_list": {"site": []}, "sponsor_list": {"sponsor": [{"is_principal_sponsor": "Y", "sponsor_name": "The University of Hong Kong", "sponsor_protocol_no": "", "sponsor_roles": "sponsor"}]}, "staff_list": {"protocol_staff": []}, "status": "open to accrual", "summary": "The goal of this randomized controlled trial is to investigate the effects of Tai-Chi and aerobic exercise on the emotional symptom cluster, and the underlying mechanism of that cluster, in late-stage lung cancer patients. Participants will be randomized into one of three groups: 1) Tai-Chi group, 2) aerobic exercise group, or 3) self-management control group. Both the Tai-Chi and aerobic exercise groups will attend twice-weekly group classes for 16 weeks (32 total contact hours). The self-management control group will receive written information regarding the recommended level of physical activity.", "treatment_list": {"step": [{"arm": [{"arm_code": "Tai-Chi intervention group", "arm_internal_id": 0, "arm_description": "The standardized 16-form Yang-style Tai-Chi exercise set will be adopted.", "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Behavioral: Tai-Chi intervention", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "Aerobic exercise intervention", "arm_internal_id": 1, "arm_description": "The aerobic exercise class will be designed to cover both aerobic and resistance exercises.", "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Behavioral: Aerobic exercise intervention", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "Self-management control group", "arm_internal_id": 2, "arm_description": "Patients in this group will receive written information regarding the recommended levels of exercise (i.e., at least 150 min of moderate-intensity or 75 min of vigorous-intensity aerobic exercise every week) that they can perform at home (self-management) while continuing to receive their standard treatment. They will also be provided with a daily exercise log to record their exercise type, frequency, and intensity.", "arm_suspended": "N", "dose_level": []}], "match": [{"and": [{"clinical": {"oncotree_primary_diagnosis": "", "disease_status": ["", ""]}}, {"genomic": {"hugo_symbol": "", "variant_category": ""}}]}]}]}}